Talus Bio

Discovering drugs that target the DNA regulome

Seattle, United States · Founded 2020 · $24.7M raised

Employees
11–50
Founded
2020
Business Model
B2B
Website
talus.bio
Total Funding
$24.7M
Last Round
$11.2M Venture RoundAug 2024
Rounds
8

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 8 funding rounds and 1 investor for this company. The full record is or through the API.

About

We have built a platform that enables drug discovery and development for previously undruggable genome regulators ("the regulome"). We accomplish this by moving drug discovery out of artificial systems where regulome proteins fail to function properly, and back into live human cells. Our technology combines innovations in automated cell processing, next-gen proteomics, and advanced data analytics to measure a drug's effect on the entire regulome in one experiment.

Summary

Talus Bio is a Biotech company based in Seattle, United States, founded in 2020. It has raised $24.7M in total across 8 rounds, most recently a $11.2M Venture Round in Aug 2024. Investors include National Cancer Institute.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture RoundAug 2024
$11.2M

Sign up to see all 8 events

Funding: Pre-Seed through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
GRAILIPO

Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...

Menlo Park, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$2.1BJun 2026
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Ultima Genomics

Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...

Fremont, United States201–500Artificial Intelligence, Healthcare
Series ETotal funding$1.1BJun 2022
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Talus Bio on Indexed.vc
<a href="https://indexed.vc/companies/talus-bio"><img src="https://indexed.vc/api/badge/company/talus-bio" alt="Talus Bio on Indexed.vc" width="260" height="76" /></a>